X-Linked Dominant Scapuloperoneal Myopathy
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About X-Linked Dominant Scapuloperoneal Myopathy

What is the definition of X-Linked Dominant Scapuloperoneal Myopathy?
X-linked scapuloperoneal myopathy is an inherited muscular dystrophy characterized by weakness and wasting of the muscles in the lower legs and the area of the shoulder blades. In some individuals, facial muscles may also be affected. Some cases of scapuloperoneal myopathy are caused by genetic changes in the FHL1 gene. These cases are inherited in an X-linked dominant manner.
What are the alternative names for X-Linked Dominant Scapuloperoneal Myopathy?
  • X-linked dominant scapuloperoneal myopathy
  • SPM
  • Scapuloperoneal myopathy, FHL1-related
  • Scapuloperoneal myopathy, X-linked dominant
  • X-linked SPMD
  • X-linked scapuloperoneal muscular dystrophy
  • X-linked scapuloperoneal syndrome
Who are the top X-Linked Dominant Scapuloperoneal Myopathy Local Doctors?
Elite in X-Linked Dominant Scapuloperoneal Myopathy
Elite in X-Linked Dominant Scapuloperoneal Myopathy
Referral may be required
Warsaw, MZ, PL 

Agnieszka Pilarczyk-Madej practices practicing medicine in Warsaw, Poland. Ms. Pilarczyk-Madej is rated as an Elite expert by MediFind in the treatment of X-Linked Dominant Scapuloperoneal Myopathy. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Emery-Dreifuss Muscular Dystrophy, X-Linked Dominant Scapuloperoneal Myopathy, X-Linked Cardiac Valvular Dysplasia, and Hypotonia.

Elite in X-Linked Dominant Scapuloperoneal Myopathy
Elite in X-Linked Dominant Scapuloperoneal Myopathy
Referral may be required
Bologna, IT 

Vittoria Cenni practices practicing medicine in Bologna, Italy. Ms. Cenni is rated as an Elite expert by MediFind in the treatment of X-Linked Dominant Scapuloperoneal Myopathy. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Acrorenal Mandibular Syndrome, Mandibuloacral Dysplasia, X-Linked Dominant Scapuloperoneal Myopathy, and Emery-Dreifuss Muscular Dystrophy.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in X-Linked Dominant Scapuloperoneal Myopathy
Family Medicine
Advanced in X-Linked Dominant Scapuloperoneal Myopathy
Family Medicine

Advocate Medical Group Primary Care

Chicago, IL 
Languages Spoken:
English
Accepting New Patients

Sam Fatoorehchi is a primary care provider, practicing in Family Medicine in Chicago, Illinois. Dr. Fatoorehchi is rated as an Advanced provider by MediFind in the treatment of X-Linked Dominant Scapuloperoneal Myopathy. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Walker-Warburg Syndrome, Fukuyama Type Muscular Dystrophy, Oculopharyngeal Muscular Dystrophy, and X-Linked Dominant Scapuloperoneal Myopathy. Dr. Fatoorehchi is board certified in American Board Of Family Medicine. Dr. Fatoorehchi is currently accepting new patients.

What are the latest X-Linked Dominant Scapuloperoneal Myopathy Clinical Trials?
Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies)

Summary: Laminopathies and emerinopathies are complex group of rare disorders due to mutations in A-type lamins (LMNA) and Emerin (EMD) genes. Among them, disorders affecting skeletal and/or cardiac muscles are the most frequent clinical manifestations, with cardiac disease being a major cause of death. Remarkable progress has been made in the description of the clinical and genetic spectrum of these disea...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Congenital Muscle Disease Patient and Proxy Reported Outcome Study

Summary: The Congenital Muscle Disease Patient and Proxy Reported Outcome Study (CMDPROS) is a longitudinal 10 year study to identify and trend care parameters, adverse events in the congenital muscle diseases using the Congenital Muscle Disease International Registry (CMDIR) to acquire necessary data for adverse event calculations (intake survey and medical records curation). To support this study and bec...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center